LMAT

LMAT

USD

LeMaitre Vascular Inc. Common Stock

$86.820+3.820 (4.602%)

Reaalajas hind

Healthcare
Medical Instruments & Supplies
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$83.000

Kõrge

$89.010

Madal

$81.570

Maht

0.06M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

2.0B

Tööstusharu

Medical Instruments & Supplies

Riik

United States

Kauplemisstatistika

Keskmine maht

0.17M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $71.42Praegune $86.820Kõrge $109.58

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 30. okt 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

LMAT Analysis: LeMaitre Vascular Faces Key Inflection Point Ahead of Earnings

Price Action: Volatility and Support Testing

LeMaitre Vascular (LMAT) has experienced a rollercoaster ride over the past three months. The stock surged from $81 to $93.04 in early August (+15%) but later dropped to $84.66 in late September (-9%), only to stabilize near $88.55 as of October 30. Key patterns to note:

  • Support Zone Alert: The stock hovers near $89.16, a critical support level. Recent lows on October 29 ($88.33) and October 30 ($87.82) suggest sellers are testing this level.
  • Volume Contrasts: Surge days (August 6: +18%, volume 428,600) contrast sharply with the 509,700 volume crash on August 26 (-5%), indicating emotional retail trader involvement.
  • Technical Tug-of-War: Mixed signals - the MACD "death cross" warns of bearish momentum, while the OBV spike on October 30 shows sudden buying pressure.

Sentiment: Analysts Push Against Market Skepticism

  • Positive Catalyst: Barrington Research reiterated its $95 price target on October 15, implying 7.2% upside from current levels. 8 analysts collectively project a $104.62 average target (+17.9% potential).
  • Earnings Countdown: The company’s Q3 results (November 6) create a natural inflection point. Historical volatility around reporting dates could amplify moves post-announcement.
  • Market Disconnect: Despite the analyst optimism, the stock underperforms its 52-week high ($109.58) by 19% and trades below its P/E ratio of 40.81, which the model flags as "neutral" (not overvalued nor undervalued).

Predictive Outlook: AI Detects Short-Term Momentum

AI models project a cautious upside over 3 days:

  • Day 1: +0.2% (flat move, low confidence)
  • Day 2: +2.6% (strongest signal)
  • Day 3: +2.3% (sustained momentum) Combined with the $91.57 AI target, this suggests potential rebound energy if support at $89.16 holds. However, the technical DMI (-DI 12.5 vs. +DI 8.8) warns of unresolved bearish pressure.

Strategic Guidance: Play the Range, Watch Debt Shadows

Entry Opportunities: If volume surges above 150,000, consider nibbling at shares near the support cluster ($89.09-$90.30). The technical setup favors a bounce, but the high debt-to-equity ratio (51.

Seotud uudised

Analyst Upgrades

Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular with a Outperform and maintains $95 price target.

Vaata rohkem
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target
GlobeNewswire

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market

Vaata rohkem
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 10. nov 2025, 10:37

LangevNeutraalneTõusev

63.1% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Mõõdukas
Kauplemisjuhend

Sisenemispunkt

$86.47

Võta kasum

$88.43

Peata kahjum

$78.02

Põhitegurid

DMI näitab langustrendi (ADX:6.4, +DI:22.2, -DI:22.5), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($86.60) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 9.9x keskmisest (2,018), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0663 on signaalijoone 0.0715 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.